Video

Q&A With Alan J. Thompson of University College London: Treatment of Progressive Multiple Sclerosis a High Priority in Medical Field

Author(s):

Treatment of the relapsing form of multiple sclerosis has come a long way in recent years. The hope by researchers now is that treatment for progressive multiple sclerosis could be coming up sooner rather than later.

Treatment of the relapsing form of multiple sclerosis has come a long way in recent years. The hope by researchers now is that treatment for progressive multiple sclerosis could be coming up sooner rather than later.

Alan J. Thompson, MD, FRCP, from University College in London discussed how work to finding treatment has progressed. Part of that effort, he said, has been finding a uniformed definition for the condition. By identifying targets, he said it can help work move forward to helping the patients that need it.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.